Press Release IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx 13 hours ago
Press Release iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1×1 Conference Aug 4
Press Release iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication Jul 23